医学临床研究
  2025年6月17日 星期二           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2019, Vol. 36 Issue (2): 303-305    DOI: 10.3969/j.issn.1671-7171.2019.02.030
  论著 本期目录 | 过刊浏览 | 高级检索 |
腋窝淋巴结结外转移对老年乳腺癌患者生存状况的影响
王旷, 李桂梅
辽宁省朝阳市第二医院,辽宁 朝阳 122000
Influence of Axillary Lymph Node Extranodal Metastasis on Survival status of Elderly Patients with Breast Cancer
WANG Kuang, LI Gui-mei
The Second Hospital of Chaoyang Liaoning. Chaoyang. Liaoning Province 122000
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨老年乳腺癌患者腋窝淋巴结结外转移情况对其生存状况的影响。方法 回顾性分析2014年10月至2016年10月于本院收治的106例老年原发浸润性乳腺癌患者的临床病理资料,分析患者肿瘤大小、雌激素受体(ER)和孕激素受体(PR)状态、组织学分化、淋巴结转移阳性数、Ⅰ~Ⅱ水平淋巴结转移个数、腋窝淋巴结转移情况与无复发生存率(RFS)以及总体生存率(OS)等预后情况相关性。采用Kaplan-Meier生存分析法,分析单纯腋窝淋巴结患者和腋窝淋巴结转移伴随腋窝淋巴结结外转移患者RFS、OS差异。结果 单因素分析结果显示,肿瘤大小、淋巴结转移阳性数、Ⅰ~Ⅱ水平淋巴结转移个数影响腋窝淋巴结结外转移,差异均具有统计学意义(P<0.05)。Cox多因素分析显示,肿瘤大小、淋巴结阳性转移个数、淋巴转移率、腋窝淋巴结转移情况是发生RFS、OS的危险因素,差异均具有统计学意义(P<0.05)。Kaplan-Meier生存分析显示,单纯腋窝淋巴结患者RFS为73.68%(42/57),OS为91.22%(52/57);腋窝淋巴结转移伴随腋窝淋巴结结外转移患者的RFS为32.65%(16/49),OS为44.80%(22/49),均低于单纯腋窝淋巴结患者,经Log-Rank检验,差异均具有统计学意义(P<0.05)。结论 肿瘤大小、淋巴结阳性、淋巴结转移个数、淋巴转移率、腋窝淋巴结转移情况影响患者RFS、OS的危险因素,可作为老年乳腺癌患者预后状况的判断指标。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王旷
李桂梅
关键词 乳腺肿瘤淋巴结老年人    
AbstractObjective To investigate the impact of axillary lymph node metastasis on the survival of elderly women with breast cancer. Methods The clinical and pathological data of 106 elderly patients with primary invasive breast cancer admitted to our hospital from October 2014 to October 2016 were retrospectively analyzed. The tumor size, estrogen receptor (ER) and progesterone receptor (PR) status, histological differentiation, positive number of lymph node metastasis, number of lymph node metastasis at level Ⅰ~Ⅱ, axillary lymph node metastasis and recurrence-free survival rate (RFS) were analyzed. ) Prognostic correlations such as overall survival rate (OS) were also discussed. Kaplan-Meier survival analysis was used to analyze the differences of RFS and OS between patients with simple axillary lymph node metastasis and those with extranodal axillary lymph node metastasis.Results Univariate analysis showed that the size of tumor, the number of positive lymph node metastasis and the number of lymph node metastasis at Ⅰ~Ⅱ level had significant effect on the extranodal metastasis of axillary lymph node (P<0.05). Cox multivariate analysis showed that the number of lymph node metastasis at the level of Ⅰ~Ⅱ had statistical significance. The size of tumor, the number of lymph node positive metastasis, the rate of lymph node metastasis and axillary lymph node metastasis were the risk factors of RFS,OS, the difference was statistically significant (P<0 05). The survival analysis of Kaplan-Meier showed that there was no significant difference between the two groups (P<0 05). In patients with axillary lymph node alone, RFS was 73.68% (42 / 57), OS, 91.22%(52/57). The RFS in patients with axillary lymph node metastasis with axillary lymph node extranodal metastasis was 32.65% (16 / 49), OS 44.80%( 22 / 49), which was lower than that in patients with simple axillary lymph node metastasis. Log-Rank test was performed on the patients with axillary lymph node metastasis and extranodal metastasis. The difference was statistically significant (P<0.05).Conclusion Tumor size, positive lymph node, number of lymph node metastasis, rate of lymph node metastasis and axillary lymph node metastasis can be used as risk factors of RFS,OS in elderly patients with breast cancer.
Key wordsBreast Neoplasms    Lymph Nodes    Aged
收稿日期: 2018-07-26     
PACS:  R737.9  
引用本文:   
王旷, 李桂梅. 腋窝淋巴结结外转移对老年乳腺癌患者生存状况的影响[J]. 医学临床研究, 2019, 36(2): 303-305.
WANG Kuang, LI Gui-mei. Influence of Axillary Lymph Node Extranodal Metastasis on Survival status of Elderly Patients with Breast Cancer. JOURNAL OF CLINICAL RESEARCH, 2019, 36(2): 303-305.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2019.02.030     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2019/V36/I2/303
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn